ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

TYR Tyratech (DI/S)

2.95
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Tyratech (DI/S) LSE:TYR London Ordinary Share COM SHS USD0.001 (DI / REGS)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.95 2.70 3.20 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

TyraTech, Inc. Appointment of Chief Financial Officer & Treasurer (2020C)

15/01/2015 7:00am

UK Regulatory


Tyratech (LSE:TYR)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Tyratech Charts.

TIDMTYR TIDMTYRU

RNS Number : 2020C

TyraTech, Inc.

15 January 2015

15 January 2015

TyraTech, Inc.

("TyraTech" or the "Company")

Appointment of Chief Financial Officer and Treasurer

TyraTech, Inc. (AIM: TYR and TYRU), a life sciences company focusing on nature-derived insect and parasite control products, announces the appointment of Vincent T. "Vince" Morgus MBA, CPA, as Chief Financial Officer and Treasurer effective immediately.

Mr Morgus takes over from Daniel Williams who is retiring following a long and successful career.

Mr Morgus, an American national, earned a BS in Accounting from Pennsylvania State University and an MBA from the University of North Carolina at Chapel Hill. He held positions at firms including Ernst & Young and Arthur Andersen before joining Quintiles, USA in 1994, the world's largest provider of biopharmaceutical development and outsourcing services. Mr Morgus spent 16 plus years in senior positions at Quintiles, including Director, Finance, Treasurer, VP, Business Operations Planning and Analysis, Interim Chief Financial Officer (Quintiles, Tokyo), and finally as Senior Vice President, Corporate Development.

More recently, Mr Morgus held the position of Chief Financial Officer with Cornerstone Therapeutics, Inc. a publicly traded speciality pharmaceutical company with approximately 100 employees.

Prior to joining Tyratech, Mr Morgus was Chief Financial Officer with Lulu Press, Inc. a private self-publishing ecommerce company with approximately 80 employees.

Bruno Jactel, CEO of TyraTech, said: "We are delighted that Vince has joined TyraTech as Chief Financial Officer. He is a proven finance leader and corporate developer and his considerable experience will be invaluable to the Company as we continue to expand into the retail markets of the USA and Europe. I would also like to thank Daniel Williams for his substantial contribution to the Company since 2007 and wish him all the best for the future."

For further information please contact:

 
 TyraTech Inc.                                 Tel: +1 919 415 4340 
  Bruno Jactel, Chief Executive Officer         Tel: +1-919-415-4287 
  Vincent Morgus, Chief Financial Officer       Tel: +44 78 4197 8709 
  Alan Reade, Non-Executive Chairman 
 SPARK Advisory Partners Limited, Nominated    Tel: +44 20 3368 3551 
  Adviser 
  Matt Davis / Mark Brady 
 Allenby Capital Limited, Joint Broker         Tel: +44 20 3328 5656 
  Chris Crawford 
 Whitman Howard, Joint Broker                  Tel: 44 20 7087 4550 
  Ranald McGregor-Smith/ Niall Devins 
 Walbrook, Financial PR and IR                 Tel: +44 20 7933 8792 
  Bob Huxford /Guy McDougall 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCLLFEDLAISLIE

1 Year Tyratech Chart

1 Year Tyratech Chart

1 Month Tyratech Chart

1 Month Tyratech Chart

Your Recent History

Delayed Upgrade Clock